Winthrop Advisory Group »

Karyopharm Therapeutics shares owned by Winthrop Advisory Group

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Winthrop Advisory Group from 13F filings

Historical chart of Winthrop Advisory Group investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Winthrop Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Winthrop Advisory Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $13k 15k 0.83
2024-06-30 $13k 15k 0.87
2024-03-31 $23k 15k 1.51

More positions owned by Winthrop Advisory Group

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Rus 1000 Etf (IWB)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ssga Active Tr Spdr Dbleln Shrt (STOT)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)
Spdr Ser Tr Portfoli S&p1500 (SPTM)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Ishares Tr Msci Acwi Ex Us (ACWX)
Ishares Tr Rus 1000 Grw Etf (IWF)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p Mcp Etf (IJH)
Microsoft Corporation (MSFT)
Vanguard Index Fds Extend Mkt Etf (VXF)

View all positions for Winthrop Advisory Group

Top funds holding Karyopharm Therapeutics

Vanguard Group
Palo Alto Investors
BlackRock
BlackRock
Citadel Advisors
Goldman Sachs Group
Marshall Wace
Avidity Partners Management
Bnp Paribas Arbitrage, Snc
GSA Capital Partners
CAM Group Holding A/S
Jpmorgan Chase & Co
Geode Capital Management
Deutsche Bank Aktiengesellschaft
Renaissance Technologies

View all funds holding Karyopharm Therapeutics